Assistant Professor, Internal Medicine, Washington University School of Medicine
Oncology
Dr. Timothy J. Pluard, MD
|
|
Give Review
Timothy Pluard works in the field of Oncology. He attended Washington University School of Medicine in St. Louis. Timothy J. Pluard, MD is also a published MD. He has 12 paper published. The most recent paper is: CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer. Dr. Timothy J. Pluard accepts Medicare payments and is registered with Medicare.gov.
Publications
- CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.
- Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic ...
- A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer.
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts.
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast Cancer.
- A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast Cancer.
- A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
- A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
- Metastatic invasive breast Cancer recurrence following curative-intent therapy for ductal carcinoma in situ.
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast Cancer: an open label, randomised, phase 2 trial.
- Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast Cancer.
Schools
Washington Center School of Medicine
Dallas Co Hp Parkland Mem
Dana Farber Cancer Institute
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Washington University School of Medicine in St. Louis
Drug Facts
| NPI NUMBER | 1396761698 | |
| NPPES Provider LastName | PLUARD | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 641115961 | |
| NPPES Provider State | MO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 2559.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 377.0 | |
| Percent Opioid Claims | 14.73 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396761698 |
| Last Name Of The Provider | PLUARD |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Kelly N. Duty, FNP
 This Doctor is OpenDoctor Recommended.
|
|
|
Donna Fisher, NP
This Doctor is OpenDoctor Recommended.
|
|
|
Mary Kellam, NP
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clay M. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ace Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kelly B. Pendergrass, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Stephen R. Smalley, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard J. McKittrick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Shwaiki, MD
This Doctor is OpenDoctor Recommended.
|